Published in Healthcare Finance, Tax and Law Weekly, August 30th, 2006
The company reported sales of $257.0 million, a 13.2% increase compared to the same quarter last year. The rise reflects the company's May 2005 acquisition of VISX, Incorporated, as well as growth of core brands across each of its businesses. Second-quarter sales were unfavorably impacted by the planned loss of $13.2 million in sales related to the company's rationalization and repositioning initiative, soft international contact lens care sales and a 0.4% decrease related to foreign currency.
For the second quarter of 2006, AMO reported a net loss...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly